Safety and efficacy of galantamine (Reminyl) in severe Alzheimer’s disease (the SERAD study): A randomised, placebo-controlled, double-blind trial - Burns, A; Bernabei, R; Bullock, R (Lancet Neurol, 2009)
et al.